Two AI medical scribe startups are reportedly raising at sky-high valuations — but they'll need to demonstrate the ability to expand into new areas to justify the premium pricing.
Why it matters: Survival in this increasingly commoditized space depends on being more than just a scribe company, hospital leaders have told Axios.
